Last reviewed · How we verify
Anti-parasitic medications
Anti-parasitic medications is a Small molecule drug developed by Boston Medical Center. It is currently in Phase 1 development. Also known as: albendazole, ivermectin, metronidazole.
At a glance
| Generic name | Anti-parasitic medications |
|---|---|
| Also known as | albendazole, ivermectin, metronidazole |
| Sponsor | Boston Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Anti-parasitic medications CI brief — competitive landscape report
- Anti-parasitic medications updates RSS · CI watch RSS
- Boston Medical Center portfolio CI
Frequently asked questions about Anti-parasitic medications
What is Anti-parasitic medications?
Anti-parasitic medications is a Small molecule drug developed by Boston Medical Center.
Who makes Anti-parasitic medications?
Anti-parasitic medications is developed by Boston Medical Center (see full Boston Medical Center pipeline at /company/boston-medical-center).
Is Anti-parasitic medications also known as anything else?
Anti-parasitic medications is also known as albendazole, ivermectin, metronidazole.
What development phase is Anti-parasitic medications in?
Anti-parasitic medications is in Phase 1.
Related
- Manufacturer: Boston Medical Center — full pipeline
- Also known as: albendazole, ivermectin, metronidazole
- Compare: Anti-parasitic medications vs similar drugs
- Pricing: Anti-parasitic medications cost, discount & access